论文部分内容阅读
目的:探讨分析苯磺酸左旋氨氯地平联合瑞舒伐他汀钙片治疗高血压病合并高血脂症的临床效果。方法:选择2013年1月-2014年10月我院收治的高血压合并高脂血症患者70例,随机分为观察组和对照组,每组35例,对照组单纯采用苯磺酸左旋氨氯地平治疗,观察组在对照组的基础上加用瑞舒伐他汀钙片,比较两组收缩压(SBP)、舒张压(DBP)、血总胆固醇(TC)、甘油三酯(TG)水平。结果:治疗后,两组SBP、DBP、TC、TG均较治疗前明显降低,差异有统计学意义(P<0.05);与对照组治疗后比较,观察组治疗后SBP、DBP、TC、TG水平更加降低,差异有统计学意义(P<0.05)。结论:苯磺酸左旋氨氯地平联合瑞舒伐他汀钙片治疗高血压合并高脂血症能够明显的降低患者血压以及血脂水平,效果比较理想,可以推广应用。
Objective: To investigate the clinical effect of levamlodipine besylate combined with rosuvastatin calcium in the treatment of hypertension and hyperlipidemia. Methods: Seventy patients with hypertension and hyperlipidemia admitted to our hospital from January 2013 to October 2014 were randomly divided into observation group (n = 35) and control group (n = 35). The control group was treated with levamisole In the control group, rosuvastatin calcium tablets were added to the observation group. SBP, DBP, TC and TG levels were compared between the two groups. . Results: After treatment, SBP, DBP, TC, TG in both groups were significantly lower than those before treatment, the difference was statistically significant (P <0.05); compared with the control group after treatment, SBP, DBP, TC, TG The level was more reduced, the difference was statistically significant (P <0.05). Conclusion: L-amlodipine besylate combined with rosuvastatin calcium tablets can significantly reduce blood pressure and blood lipid levels in patients with hypertension and hyperlipidemia, and the effect is ideal and can be widely applied.